GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Aug 25, 2025, 4:00 PM
1.082
-0.008 (-0.74%)
After-hours: Aug 25, 2025, 6:40 PM EDT
GT Biopharma Employees
GT Biopharma had 1 employees as of December 31, 2024. The number of employees decreased by 1 or -50.00% compared to the previous year.
Employees
1
Change (1Y)
-1
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$9,480,000
Market Cap
3.88M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1 | -1 | -50.00% |
Dec 31, 2023 | 2 | 0 | - |
Dec 31, 2022 | 2 | -6 | -75.00% |
Dec 31, 2021 | 8 | 5 | 166.67% |
Dec 31, 2020 | 3 | 1 | 50.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GTBP News
- 11 days ago - GT Biopharma Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 14 days ago - GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2 - GlobeNewsWire
- 2 months ago - GT Biopharma Appoints New Member to its Board of Directors - GlobeNewsWire
- 3 months ago - GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals - GlobeNewsWire
- 6 months ago - GT Biopharma Announces Exercise of Warrants - GlobeNewsWire
- 10 months ago - GT Biopharma Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 11 months ago - GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 11 months ago - GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024 - GlobeNewsWire